Expression data for pharmacogenomics antiplatelet therapy
收藏官方服务：
资源简介：
Expression data for pharmacogenomics antiplatelet therapy
应用场景：
创建时间：
2012-09-15
相关数据集
Supplementary Material for: Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)
Background: Individuals with transient ischemic attack and ischemic stroke have a high risk of recurrent stroke and death. While acetylsalicylic acid (ASA, aspirin) is proven and accepted as st
DataCite Commons2020-09-02 更新130
Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis
Background and Purpose Antiplatelet therapy is widely used for the primary or secondary prevention of stroke. Drugs like clopidogrel have emerged as alternatives for traditional antiplatelet therapy,
NIAID Data Ecosystem70
Baseline characteristics.
Background Despite Antiplatelet therapy (APT), cardiovascular patients undergoing revascularisation remain at high risk for thrombotic events. Individual response to APT varies substantially, resultin
NIAID Data Ecosystem60
Supplementary Material for: Evaluating the Safety of Stent-Assisted Endovascular Treatment for Unruptured Cerebral Aneurysms in Older Adults: Emphasizing the Role of Antiplatelet Therapy
Introduction: This study aimed to compare the outcomes and safety in patients aged ≥75 years and those aged <75 years who underwent stent-assisted endovascular treatment for unruptured cerebral ane
DataCite Commons2024-10-10 更新90
Comparison of E . coli O157 log CFU g -1 (combined strains) in metagenomics trial.
Comparison of E. coli O157 log CFU g-1 (combined strains) in metagenomics trial.
NIAID Data Ecosystem60
